Home›Companies›Healthcare›GreenMark

GreenMark Biomedical Inc.

Dental strips and detection rinse for dental professionals and their patients.

Updated Nov 10, 2026·Latest SEC filing Apr 14, 2026·Suggest an edit

About GreenMark

GreenMark is a private company based in East Lansing, Michigan. It has reported $1,700,000 raised in five offerings on Form D since May 2018. Its chief executive is Steven Bloembergen PhD.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetApr 14, 2026$0of $5.0M target0—EquityRule 506(b)Form D ↗
Not yetJan 21, 2025$0of $500K target0—Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗
Oct 14, 2022Oct 31, 2022$500,000of $1.0M target3$166KDebt, OptionsRule 506(b)Form D ↗
Not yetJul 17, 2020$0of $2.0M target0—Debt, Options, Notes convertible into preferred stockRule 506(b)Form D ↗
May 11, 2018May 24, 2018amended Mar 19, 2019$1,200,000fully sold0—EquityRule 506(b)Form D/A ↗1 earlier filing
Total, five offerings$1,700,000

The filing for the offering first filed May 24, 2018 reports amount sold with no investors. Figures are shown as filed.

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on GreenMark's Form D filed Apr 14, 2026.

Earlier filings also listed Joerg LaHann, Ph.D. (director, last listed Jan 2025), Jeff Wesley (director, last listed Oct 2022), Frank van Luttikhuizen (director, last listed Oct 2022), Kenneth Pienta (director, last listed Jul 2020), Steven Bloembergen, Ph.D. (chairman and ceo, last listed Mar 2019), Kenneth Pienta, M.D. (director, last listed Mar 2019) and Frank van Luttikhuizen, CPA (director, last listed Mar 2019).

Sources

  1. SECGreenMark Biomedical Inc. Form D, filed May 24, 2018
  2. SECGreenMark Biomedical Inc. filing history
  3. CompanyManagement team
  4. CompanyPrivacy policy